Search
for
Sort by
Research 211–240 of 1000+
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin
- Psoriasiform skin reaction due to Brazilian keratin treatment
- Multiple minute digitate hyperkeratosis
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation
- British Cosmetic Dermatology Group
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Dermatological drugs, topical agents, and cosmetics
- Plant Extracts in Skin Care Products
- 4. Bullous/Mucous Membrane
- Nanoparticles enhance therapeutic outcome in inflamed skin therapy
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Atypical bilateral hyperpigmented macules on the lower legs possibly due to cyclophosphamide.
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Serum drug level-related sodium valproate-induced hair loss
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- P‐51 Drug‐induced erythema multiforme or drug‐induced pemphigus foliaceus: a case report
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- The potential application of natural products in cutaneous wound healing: A review of preclinical evidence
- Drug‐Induced Liver Failure Following Topical Minoxidil: A Case Report
- New treatments for rheumatoid arthritis
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge